(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBP1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of FBP1 mRNA CTD PMID:16988119 1,1-dichloroethene decreases expression ISO RGD:731473 6480464 vinylidene chloride results in decreased expression of FBP1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:731473 6480464 ethylene dichloride results in decreased expression of FBP1 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:731473 6480464 1, 2-Dimethylhydrazine results in decreased expression of FBP1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:731473 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBP1 mRNA CTD PMID:22206623 1-benzylpiperazine decreases expression EXP 6480464 N-benzylpiperazine results in decreased expression of FBP1 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate multiple interactions ISO RGD:735552 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FBP1 mRNA CTD PMID:27344345 17beta-estradiol increases expression ISO RGD:735552 6480464 Estradiol results in increased expression of FBP1 mRNA CTD PMID:19619570 , PMID:19698761 17beta-estradiol decreases expression ISO RGD:735552 6480464 Estradiol results in decreased expression of FBP1 mRNA CTD PMID:21185374 17beta-estradiol multiple interactions ISO RGD:735552 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of FBP1 mRNA CTD PMID:19619570 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:731473 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrabromodibenzodioxine increases expression ISO RGD:731473 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735552 6480464 Tetrachlorodibenzodioxin results in increased expression of FBP1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBP1 mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FBP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731473 6480464 Tetrachlorodibenzodioxin results in increased expression of FBP1 mRNA CTD PMID:16120747 , PMID:18796159 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731473 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of FBP1 mRNA CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735552 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of FBP1 mRNA CTD PMID:19619570 2,4-dinitrotoluene decreases expression ISO RGD:731473 6480464 2, 4-dinitrotoluene results in decreased expression of FBP1 mRNA CTD PMID:24893713 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of FBP1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:735552 6480464 Lactic Acid results in decreased expression of FBP1 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 4-hydroxyphenyl retinamide increases expression ISO RGD:731473 6480464 Fenretinide results in increased expression of FBP1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO RGD:735552 6480464 Decitabine results in decreased methylation of FBP1 promoter CTD PMID:22039417 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735552 6480464 [Decitabine affects the methylation of FBP1 promoter] which affects the expression of FBP1 mRNA, [Decitabine results in decreased methylation of FBP1 promoter] which results in increased expression of FBP1 mRNA CTD PMID:18938139 , PMID:22039417 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of FBP1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of FBP1 mRNA CTD PMID:19483382 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FBP1 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:731473 6480464 Aflatoxin B1 results in decreased expression of FBP1 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:735552 6480464 Aflatoxin B1 results in decreased expression of FBP1 mRNA CTD PMID:27153756 , PMID:32234424 Aflatoxin B2 alpha increases methylation ISO RGD:735552 6480464 aflatoxin B2 results in increased methylation of FBP1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:731473 6480464 Tretinoin results in increased expression of FBP1 mRNA CTD PMID:16788091 all-trans-retinoic acid decreases expression ISO RGD:735552 6480464 Tretinoin results in decreased expression of FBP1 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:735552 6480464 Tretinoin results in increased expression of FBP1 mRNA CTD PMID:15498508 , PMID:33167477 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of FBP1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FBP1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:735552 6480464 Antirheumatic Agents results in decreased expression of FBP1 mRNA CTD PMID:24449571 apigenin decreases expression ISO RGD:735552 6480464 Apigenin results in decreased expression of FBP1 mRNA CTD PMID:18331776 arsenous acid multiple interactions ISO RGD:731473 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of FBP1 mRNA] CTD PMID:30362509 arsenous acid increases expression ISO RGD:735552 6480464 Arsenic Trioxide results in increased expression of FBP1 protein CTD PMID:25419056 arsenous acid increases expression ISO RGD:731473 6480464 Arsenic Trioxide results in increased expression of FBP1 mRNA CTD PMID:30362509 arsenous acid decreases expression ISO RGD:735552 6480464 Arsenic Trioxide results in decreased expression of FBP1 mRNA CTD PMID:19128835 ATP multiple interactions ISO RGD:731473 6480464 [Enzyme Inhibitors results in decreased activity of FBP1 protein] which results in decreased abundance of Adenosine Triphosphate CTD PMID:31974165 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of FBP1 mRNA CTD PMID:19483382 benzo[a]pyrene increases methylation ISO RGD:735552 6480464 Benzo(a)pyrene results in increased methylation of FBP1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:735552 6480464 Benzo(a)pyrene results in decreased expression of FBP1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:735552 6480464 Benzo(a)pyrene affects the methylation of FBP1 5' UTR, Benzo(a)pyrene affects the methylation of FBP1 intron CTD PMID:27901495 , PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:735552 6480464 benzo(e)pyrene results in increased methylation of FBP1 intron CTD PMID:30157460 beta-D-fructofuranose 2,6-bisphosphate decreases activity ISO RGD:731473 6480464 fructose 2, 6-diphosphate results in decreased activity of FBP1 protein CTD PMID:31974165 bifenthrin increases expression ISO RGD:731473 6480464 bifenthrin results in increased expression of FBP1 mRNA CTD PMID:26071804 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBP1 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A increases expression ISO RGD:731473 6480464 bisphenol A results in increased expression of FBP1 mRNA CTD PMID:30245210 , PMID:33221593 bisphenol A decreases expression ISO RGD:735552 6480464 bisphenol A results in decreased expression of FBP1 mRNA CTD PMID:31121516 calcitriol increases expression ISO RGD:735552 6480464 Calcitriol results in increased expression of FBP1 mRNA CTD PMID:26485663 carbon nanotube increases expression ISO RGD:731473 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:27106021 chlorpromazine multiple interactions ISO RGD:735552 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of FBP1 mRNA CTD PMID:27344345 chromium trinitrate increases expression ISO RGD:731473 6480464 chromium nitrate results in increased expression of FBP1 protein CTD PMID:22144121 chromium(6+) affects expression ISO RGD:731473 6480464 chromium hexavalent ion affects the expression of FBP1 mRNA CTD PMID:28472532 chrysin decreases expression ISO RGD:735552 6480464 chrysin results in decreased expression of FBP1 mRNA CTD PMID:18331776 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of FBP1 protein CTD PMID:22023808 citronellol multiple interactions EXP 6480464 citronellol inhibits the reaction [Streptozocin results in increased activity of FBP1 protein] CTD PMID:26944432 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of FBP1 mRNA CTD PMID:19483382 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FBP1 protein CTD PMID:16470657 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of FBP1 mRNA CTD PMID:17602206 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FBP1 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:735552 6480464 Copper Sulfate results in decreased expression of FBP1 mRNA CTD PMID:19549813 cyclosporin A multiple interactions ISO RGD:735552 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of FBP1 mRNA CTD PMID:27344345 D-glucopyranose 6-phosphate multiple interactions ISO RGD:731473 6480464 [Enzyme Inhibitors results in decreased activity of FBP1 protein] which results in decreased abundance of Glucose-6-Phosphate CTD PMID:31974165 diarsenic trioxide multiple interactions ISO RGD:731473 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of FBP1 mRNA] CTD PMID:30362509 diarsenic trioxide increases expression ISO RGD:731473 6480464 Arsenic Trioxide results in increased expression of FBP1 mRNA CTD PMID:30362509 diarsenic trioxide increases expression ISO RGD:735552 6480464 Arsenic Trioxide results in increased expression of FBP1 protein CTD PMID:25419056 diarsenic trioxide decreases expression ISO RGD:735552 6480464 Arsenic Trioxide results in decreased expression of FBP1 mRNA CTD PMID:19128835 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of FBP1 protein CTD PMID:21161181 dimethylarsinic acid multiple interactions ISO RGD:731473 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA CTD PMID:34876320 elemental selenium increases expression ISO RGD:731473 6480464 Selenium results in increased expression of FBP1 mRNA CTD PMID:28810182 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBP1 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:731473 6480464 [Enzyme Inhibitors results in decreased activity of FBP1 protein] which results in decreased abundance of Adenosine Triphosphate more ... CTD PMID:31974165 enzyme inhibitor decreases activity ISO RGD:731473 6480464 Enzyme Inhibitors results in decreased activity of FBP1 protein CTD PMID:31974165 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of FBP1 mRNA CTD PMID:23962444 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of FBP1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:731473 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBP1 mRNA CTD PMID:22206623 fructose increases activity EXP 6480464 Fructose results in increased activity of FBP1 protein CTD PMID:16920846 fructose increases expression EXP 6480464 Fructose results in increased expression of FBP1 mRNA CTD PMID:15150374 , PMID:18346472 fructose multiple interactions EXP 6480464 Vanadates inhibits the reaction [Fructose results in increased activity of FBP1 protein] CTD PMID:16920846 fumonisin B1 decreases expression ISO RGD:731473 6480464 fumonisin B1 results in decreased expression of FBP1 mRNA CTD PMID:16221962 furan affects binding EXP 6480464 furan binds to FBP1 protein CTD PMID:22240984 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of FBP1 mRNA CTD PMID:33387578 glyceraldehyde 3-phosphate multiple interactions ISO RGD:731473 6480464 [Enzyme Inhibitors results in decreased activity of FBP1 protein] which results in decreased abundance of Glyceraldehyde 3-Phosphate metabolite CTD PMID:31974165 hydrazine increases expression EXP 6480464 hydrazine results in increased expression of FBP1 protein CTD PMID:15370871 isotretinoin decreases expression ISO RGD:735552 6480464 Isotretinoin results in decreased expression of FBP1 mRNA CTD PMID:20436886 kaempferol decreases expression ISO RGD:735552 6480464 kaempferol results in decreased expression of FBP1 mRNA CTD PMID:18331776 L-ascorbic acid affects expression ISO RGD:731473 6480464 Ascorbic Acid affects the expression of FBP1 protein CTD PMID:19224539 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of FBP1 mRNA CTD PMID:19483382 lipopolysaccharide multiple interactions ISO RGD:735552 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FBP1 mRNA CTD PMID:35811015 luteolin decreases expression ISO RGD:735552 6480464 Luteolin results in decreased expression of FBP1 mRNA CTD PMID:18331776 mangiferin decreases expression ISO RGD:731473 6480464 mangiferin results in decreased expression of FBP1 mRNA CTD PMID:19028559 metformin decreases expression EXP 6480464 Metformin results in decreased expression of FBP1 mRNA CTD PMID:19022234 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of FBP1 mRNA CTD PMID:16393664 , PMID:30467583 methapyrilene increases methylation ISO RGD:735552 6480464 Methapyrilene results in increased methylation of FBP1 intron CTD PMID:30157460 methylarsonic acid multiple interactions ISO RGD:731473 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA CTD PMID:34876320 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of FBP1 mRNA CTD PMID:21515302 myricetin decreases expression ISO RGD:735552 6480464 myricetin results in decreased expression of FBP1 mRNA CTD PMID:18331776 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions ISO RGD:731473 6480464 N-(3, 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Particulate Matter results in increased expression of FBP1 protein] CTD PMID:29635361 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of FBP1 protein CTD PMID:19716841 naphthalene increases expression ISO RGD:731473 6480464 naphthalene results in increased expression of FBP1 mRNA CTD PMID:18978301 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FBP1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:735552 6480464 methyleugenol results in decreased expression of FBP1 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO RGD:735552 6480464 obeticholic acid results in decreased expression of FBP1 mRNA CTD PMID:27939613 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of FBP1 protein CTD PMID:31369848 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of FBP1 mRNA CTD PMID:19483382 paracetamol affects expression ISO RGD:731473 6480464 Acetaminophen affects the expression of FBP1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FBP1 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:731473 6480464 [CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in decreased expression of FBP1 protein, PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of FBP1 mRNA] CTD PMID:25499718 , PMID:29246445 paracetamol decreases expression ISO RGD:731473 6480464 Acetaminophen results in decreased expression of FBP1 mRNA, Acetaminophen results in decreased expression of FBP1 protein CTD PMID:22939915 , PMID:29246445 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of FBP1 mRNA CTD PMID:32680482 perfluorooctanoic acid multiple interactions ISO RGD:731473 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:20118188 , PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:731473 6480464 perfluorooctanoic acid results in decreased expression of FBP1 mRNA CTD PMID:20118188 , PMID:23626681 pirinixic acid multiple interactions ISO RGD:731473 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of FBP1 mRNA CTD PMID:20813756 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of FBP1 mRNA CTD PMID:19483382 pirinixic acid decreases expression ISO RGD:731473 6480464 pirinixic acid results in decreased expression of FBP1 mRNA, pirinixic acid results in decreased expression of FBP1 protein CTD PMID:15226431 , PMID:20813756 potassium chromate increases expression ISO RGD:731473 6480464 potassium chromate(VI) results in increased expression of FBP1 protein CTD PMID:22144121 potassium dichromate decreases expression ISO RGD:731473 6480464 Potassium Dichromate results in decreased expression of FBP1 mRNA CTD PMID:23608068 propiconazole decreases expression ISO RGD:731473 6480464 propiconazole results in decreased expression of FBP1 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:735552 6480464 Quercetin results in decreased expression of FBP1 mRNA CTD PMID:18331776 rac-lactic acid decreases expression ISO RGD:735552 6480464 Lactic Acid results in decreased expression of FBP1 mRNA CTD PMID:30851411 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735552 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FBP1 mRNA CTD PMID:35811015 selenic acid decreases expression ISO RGD:731473 6480464 Selenic Acid results in decreased expression of FBP1 mRNA CTD PMID:16443359 selenic acid decreases activity ISO RGD:731473 6480464 Selenic Acid results in decreased activity of FBP1 protein CTD PMID:16443359 selenium atom increases expression ISO RGD:731473 6480464 Selenium results in increased expression of FBP1 mRNA CTD PMID:28810182 sodium arsenate multiple interactions ISO RGD:731473 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:735552 6480464 sodium arsenite results in decreased expression of FBP1 protein CTD PMID:24866292 sodium arsenite multiple interactions ISO RGD:731473 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of FBP1 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:735552 6480464 sodium arsenite results in increased expression of FBP1 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of FBP1 protein CTD PMID:29459688 sodium chlorate decreases activity EXP 6480464 sodium chlorate results in decreased activity of FBP1 protein CTD PMID:28084674 sodium dichromate decreases expression ISO RGD:735552 6480464 sodium bichromate results in decreased expression of FBP1 mRNA, sodium bichromate results in decreased expression of FBP1 protein CTD PMID:28624442 sodium dichromate multiple interactions ISO RGD:735552 6480464 FBP1 protein inhibits the reaction [sodium bichromate results in decreased expression of JUN protein] more ... CTD PMID:28624442 sodium dichromate affects response to substance ISO RGD:735552 6480464 FBP1 protein affects the susceptibility to sodium bichromate CTD PMID:28624442 streptozocin multiple interactions EXP 6480464 citronellol inhibits the reaction [Streptozocin results in increased activity of FBP1 protein] CTD PMID:26944432 streptozocin increases activity EXP 6480464 Streptozocin results in increased activity of FBP1 protein CTD PMID:26944432 succimer multiple interactions ISO RGD:735552 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FBP1 mRNA CTD PMID:26378955 tamibarotene increases expression ISO RGD:735552 6480464 tamibarotene results in increased expression of FBP1 mRNA CTD PMID:15498508 taurine multiple interactions ISO RGD:731473 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of FBP1 mRNA] CTD PMID:30362509 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of FBP1 mRNA CTD PMID:21515302 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FBP1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBP1 mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:735552 6480464 Thapsigargin results in decreased expression of FBP1 mRNA CTD PMID:22378314 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of FBP1 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FBP1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:731473 6480464 titanium dioxide affects the expression of FBP1 mRNA CTD PMID:23557971 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FBP1 mRNA CTD PMID:30012374 trichostatin A multiple interactions ISO RGD:735552 6480464 [trichostatin A affects the methylation of FBP1 promoter] which affects the expression of FBP1 mRNA CTD PMID:18938139 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of FBP1 mRNA CTD PMID:21515302 tunicamycin decreases expression ISO RGD:731473 6480464 Tunicamycin results in decreased expression of FBP1 mRNA CTD PMID:17127020 tunicamycin decreases expression ISO RGD:735552 6480464 Tunicamycin results in decreased expression of FBP1 mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:731473 6480464 Valproic Acid affects the expression of FBP1 mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:735552 6480464 Valproic Acid results in increased methylation of FBP1 gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:735552 6480464 Valproic Acid results in decreased expression of FBP1 mRNA, Valproic Acid results in decreased expression of FBP1 protein CTD PMID:24935251 more ... vancomycin increases expression ISO RGD:731473 6480464 Vancomycin results in increased expression of FBP1 mRNA CTD PMID:18930951 vanillin affects binding ISO RGD:735552 6480464 vanillin binds to FBP1 protein CTD PMID:33823243 vorinostat increases expression ISO RGD:735552 6480464 vorinostat results in increased expression of FBP1 protein CTD PMID:20543569